首页 正文

JAMA network open. 2024 Jun 3;7(6):e2414431. doi: 10.1001/jamanetworkopen.2024.14431 Q19.72025

Incorporating Medicare Advantage Admissions Into the CMS Hospital-Wide Readmission Measure

将Medicare优势计划住院记录纳入CMS医院整体再入院率考核指标中 翻译改进

Kelly Kyanko  1, Kashika M Sahay  2  3, Yongfei Wang  2  3, Shu-Xia Li  3, Michelle Schreiber  4, Melissa Hager  4, Raquel Myers  4, Wanda Johnson  3, Jing Zhang  2  3, Harlan Krumholz  2  3, Lisa G Suter  2  3, Elizabeth W Triche  3

作者单位 +展开

作者单位

  • 1 Department of Population Health, New York University Grossman School of Medicine, New York.
  • 2 Yale School of Medicine, New Haven, Connecticut.
  • 3 Yale New Haven Health Services Corporation/Center for Outcomes Research & Evaluation, New Haven, Connecticut.
  • 4 Centers for Medicare & Medicaid Services, Center for Clinical Standards & Quality, Baltimore, Maryland.
  • DOI: 10.1001/jamanetworkopen.2024.14431 PMID: 38829614

    摘要 Ai翻译

    Importance: Medicare Advantage (MA) enrollment is rapidly expanding, yet Centers for Medicare & Medicaid Services (CMS) claims-based hospital outcome measures, including readmission rates, have historically included only fee-for-service (FFS) beneficiaries.

    Objective: To assess the outcomes of incorporating MA data into the CMS claims-based FFS Hospital-Wide All-Cause Unplanned Readmission (HWR) measure.

    Design, setting, and participants: This cohort study assessed differences in 30-day unadjusted readmission rates and demographic and risk adjustment variables for MA vs FFS admissions. Inpatient FFS and MA administrative claims data were extracted from the Integrated Data Repository for all admissions for Medicare beneficiaries from July 1, 2018, to June 30, 2019. Measure reliability and risk-standardized readmission rates were calculated for the FFS and MA cohort vs the FFS-only cohort, overall and within specialty subgroups (cardiorespiratory, cardiovascular, medicine, surgery, neurology), then changes in hospital performance quintiles were assessed after adding MA admissions.

    Main outcome and measure: Risk-standardized readmission rates.

    Results: The cohort included 11 029 470 admissions (4 077 633 [37.0%] MA; 6 044 060 [54.8%] female; mean [SD] age, 77.7 [8.2] years). Unadjusted readmission rates were slightly higher for MA vs FFS admissions (15.7% vs 15.4%), yet comorbidities were generally lower among MA beneficiaries. Test-retest reliability for the FFS and MA cohort was higher than for the FFS-only cohort (0.78 vs 0.73) and signal-to-noise reliability increased in each specialty subgroup. Mean hospital risk-standardized readmission rates were similar for the FFS and MA cohort and FFS-only cohorts (15.5% vs 15.3%); this trend was consistent across the 5 specialty subgroups. After adding MA admissions to the FFS-only HWR measure, 1489 hospitals (33.1%) had their performance quintile ranking changed. As their proportion of MA admissions increased, more hospitals experienced a change in their performance quintile ranking (147 hospitals [16.3%] in the lowest quintile of percentage MA admissions; 408 [45.3%] in the highest). The combined cohort added 63 hospitals eligible for public reporting and more than 4 million admissions to the measure.

    Conclusions and relevance: In this cohort study, adding MA admissions to the HWR measure was associated with improved measure reliability and precision and enabled the inclusion of more hospitals and beneficiaries. After MA admissions were included, 1 in 3 hospitals had their performance quintile changed, with the greatest shifts among hospitals with a high percentage of MA admissions.

    Keywords:medicare advantage

    Copyright © JAMA network open. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Jama network open

    缩写:

    ISSN:2574-3805

    e-ISSN:2574-3805

    IF/分区:9.7/Q1

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Incorporating Medicare Advantage Admissions Into the CMS Hospital-Wide Readmission Measure